Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Medical Device Technology (JMDT) is a specialized medical device company focused on the development and commercialization of advanced cardiovascular intervention technologies. The company is best known for its proprietary bioresorbable scaffold (BRS) technology, which aims to provide temporary support to treated arteries before being naturally absorbed by the body, thereby reducing long-term complications associated with permanent metallic stents. JMDT's product portfolio includes drug-eluting stents and balloon catheters designed for both coronary and peripheral vascular applications. Headquartered in Kumamoto, Japan, the company leverages high-precision manufacturing and material science to improve clinical outcomes in interventional cardiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology Japan.